Clin2
NCT06315972Possibly a fitNot yet recruiting

Clemastine plus exercise for thinking problems in schizophrenia

Schizophrenia

Part of Mental health clinical trials.

This study tests whether a combination of an antihistamine called clemastine plus aerobic exercise can help improve thinking and memory problems in people with schizophrenia. It aims to see if this approach can repair nerve insulation in the brain, potentially restoring cognitive function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
90 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with schizophrenia or a related disorder
  • You have been on a stable dose of your psychiatric medication for at least one week
  • You do not have certain serious medical conditions (like heart, liver, or kidney problems)
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06021197Recruiting· Phase 2
NMDA-enhancing treatment for cognitive symptoms in schizophrenia

This study tests a new treatment that may help with thinking and memory problems in people with schizophrenia. It is for people whose schizophrenia symptoms are stable and who are already on a steady medication.

Taichung
NCT07404319Not yet recruiting
Exercise with brain stimulation for thinking skills in schizophrenia

This study tests whether adding a mild brain stimulation therapy (called tDCS) to a supervised exercise program can help improve thinking and memory in people with treatment-resistant schizophrenia. The goal is to see if combining these activities works better than exercise alone.

Hong Kong
NCT01392885Recruiting
Brain health and exercise program for schizophrenia

This trial studies how a structured exercise program may affect brain health in people with schizophrenia or schizoaffective disorder. It may help researchers understand whether exercise can support brain function and overall health in this condition.

Vancouver, British Columbia
NCT03794076Recruiting· Phase 1/Phase 2
Testing adjunct cromoglicate for schizophrenia symptoms

This trial studies whether adding cromoglicate to your usual antipsychotic medicine can improve schizophrenia symptoms. It’s designed for outpatients who are already on a stable treatment and still have certain ongoing symptom scores.

Pittsburgh, Pennsylvania
NCT07745140Not yet recruiting
Brain stimulation and exercise for thinking skills in schizophrenia

This study combines brain stimulation with physical exercise to see if it can improve thinking skills in people with schizophrenia. You will receive a gentle form of brain stimulation while doing exercise.

Hung Hom, Kowloon
NCT02455193Recruiting
Exercise study for people with schizophrenia

This study looks at how exercise affects brain function in people with schizophrenia or schizoaffective disorder. It may help researchers understand whether exercise can improve brain-related outcomes alongside standard treatment.

Aurora, Colorado

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.